Adverum Biotechnologies, Inc.
ADVMDelisted Dec 9, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501756
Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in Adverum Biotechnologies, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 68
- +7 vs. Q1 2024
- Shares held
- 17.9M
- +1.11M (+6.6%) vs. Q1 2024
- Total value
- $117.7M
- −$119.2M (−50.3%) vs. Q1 2024
- New holders
- 20
- 24 more added
- Sold out
- 13
- 13 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADVM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 50 | $63.8M |
| Q2 2025 | 59 | $30.1M |
| Q1 2025 | 71 | $69.8M |
| Q4 2024 | 70 | $74.1M |
| Q3 2024 | 77 | $120.2M |
| Q2 2024 | 68 | $117.7M |
| Q1 2024 | 61 | $236.9M |
| Q4 2023 | 61 | $48.3M |
| Q3 2023 | 61 | $97.9M |
| Q2 2023 | 58 | $104.4M |
| Q1 2023 | 55 | $45.0M |
| Q4 2022 | 59 | $33.2M |
| Q3 2022 | 78 | $55.6M |
| Q2 2022 | 77 | $70.0M |
| Q1 2022 | 92 | $82.4M |
| Q4 2021 | 98 | $115.5M |
| Q3 2021 | 110 | $151.2M |
| Q2 2021 | 118 | $280.4M |
| Q1 2021 | 132 | $937.9M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Adverum Biotechnologies, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TCG Crossover Management, LLC | 2,008,340 | $13.8M | 1.44% | 00.0% | Unchanged |
| BML Capital Management, LLC | 1,966,000 | $13.5M | 9.88% | +1,132,883+136.0% | Added |
| Franklin Resources Inc | 1,760,052 | $12.1M | 0.00% | +1,084,377+160.5% | Added |
| VR Adviser, LLC | 1,467,048 | $10.1M | 0.64% | −89,371−5.7% | Reduced |
| BlackRock Inc. | 1,409,441 | $9.67M | 0.00% | +1,092,991+345.4% | Added |
| Frazier Life Sciences Management, L.P. | 1,069,244 | $7.34M | 0.34% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,009,459 | $6.92M | 0.00% | +102,308+11.3% | Added |
| FMR LLC | 637,509 | $4.37M | 0.00% | −263,018−29.2% | Reduced |
| Assenagon Asset Management S.A. | 617,910 | $4.24M | 0.01% | +259,191+72.3% | Added |
| 5AM Venture Management, LLC | 541,666 | $3.72M | 0.83% | 00.0% | Unchanged |
| Versant Venture Management, LLC | 506,821 | $3.48M | 4.50% | −10.0% | Reduced |
| Geode Capital Management, LLC | 455,787 | $3.13M | 0.00% | +262,271+135.5% | Added |
| Logos Global Management LP | 416,666 | $2.86M | 0.33% | −1,083,333−72.2% | Reduced |
| Avoro Capital Advisors LLC | 416,666 | $2.86M | 0.04% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 396,931 | $2.72M | 0.00% | +396,931 | New |
| State Street Corp | 278,504 | $1.91M | 0.00% | +213,780+330.3% | Added |
| Dimensional Fund Advisors LP | 223,427 | $1.53M | 0.00% | +196,884+741.8% | Added |
| Marshall Wace, LLP | 204,619 | $1.40M | 0.00% | +70,768+52.9% | Added |
| Bank of America Corp | 176,099 | $1.21M | 0.00% | +10,604+6.4% | Added |
| Soleus Capital Management, L.P. | 147,246 | $1.01M | 0.09% | +147,246 | New |
| Renaissance Technologies LLC | 136,257 | $934.7K | 0.00% | +3,169+2.4% | Added |
| Morgan Stanley | 129,259 | $886.7K | 0.00% | −432,776−77.0% | Reduced |
| Citadel Advisors LLC | 125,790 | $862.9K | 0.00% | +125,790 | New |
| Picton Mahoney Asset Management | 123,743 | $850.0K | 0.04% | −223−0.2% | Reduced |
| Vivo Capital, LLC | 833,333 | $833.3K | 0.08% | −666,667−44.4% | Reduced |
| Squarepoint Ops LLC | 108,978 | $747.6K | 0.00% | +81,808+301.1% | Added |
| Two Sigma Investments, LP | 77,345 | $530.6K | 0.00% | +65,503+553.1% | Added |
| Millennium Management LLC | 69,411 | $476.2K | 0.00% | −179,231−72.1% | Reduced |
| Nuveen Asset Management, LLC | 68,537 | $470.2K | 0.00% | +68,537 | New |
| Bank of New York Mellon Corp | 64,585 | $443.1K | 0.00% | +64,585 | New |
| Charles Schwab Investment Management Inc | 59,734 | $409.8K | 0.00% | +49,021+457.6% | Added |
| Northern Trust Corp | 47,163 | $323.5K | 0.00% | +10,423+28.4% | Added |
| Rhumbline Advisers | 30,821 | $211.4K | 0.00% | +30,528+10,419.1% | Added |
| Jane Street Group, LLC | 29,202 | $200.3K | 0.00% | +29,202 | New |
| Quinn Opportunity Partners LLC | 26,829 | $184.0K | 0.02% | 00.0% | Unchanged |
| Jump Financial, LLC | 24,203 | $166.0K | 0.00% | +24,203 | New |
| Two Sigma Advisers, LP | 22,901 | $157.1K | 0.00% | +6,731+41.6% | Added |
| Bank of Montreal | 16,242 | $129.9K | 0.00% | +16,242 | New |
| Qube Research & Technologies Ltd | 16,265 | $111.6K | 0.00% | −25,354−60.9% | Reduced |
| Barclays PLC | 15,867 | $108.8K | 0.00% | −37,391−70.2% | Reduced |
| Cantor Fitzgerald, L. P. | 15,446 | $106.0K | 0.02% | 00.0% | Unchanged |
| New York State Common Retirement Fund | 14,400 | $98.8K | 0.00% | +14,400 | New |
| Graham Capital Management, L.P. | 11,782 | $80.8K | 0.00% | +11,782 | New |
| ADAR1 Capital Management, LLC | 11,300 | $77.5K | 0.02% | +8,500+303.6% | Added |
| Corebridge Financial, Inc. | 11,192 | $76.9K | 0.00% | +11,192 | New |
| Bayesian Capital Management, LP | 10,756 | $73.8K | 0.01% | +10,756 | New |
| Wells Fargo & Company | 9,140 | $62.7K | 0.00% | +8,998+6,336.6% | Added |
| JPMorgan Chase & Co | 8,904 | $61.1K | 0.00% | +8,866+23,331.6% | Added |
| Advisor Group Holdings, Inc. | 8,574 | $58.8K | 0.00% | +6,524+318.2% | Added |
| UBS Group AG | 6,358 | $43.6K | 0.00% | +5,426+582.2% | Added |
| MetLife Investment Management | 5,493 | $37.7K | 0.00% | +5,493 | New |
| Citigroup Inc | 4,669 | $32.0K | 0.00% | −47,936−91.1% | Reduced |
| Northwest & Ethical Investments L.P. | 3,390 | $23.3K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,234 | $15.0K | 0.00% | +2,223+20,209.1% | Added |
| Ameritas Investment Partners, Inc. | 2,038 | $14.0K | 0.00% | +2,038 | New |
| Legal & General Group Plc | 1,797 | $12.3K | 0.00% | +1,797 | New |
| California State Teachers Retirement System | 1,507 | $10.3K | 0.00% | +1,507 | New |
| BNP Paribas Arbitrage, SA | 1,497 | $10.3K | 0.00% | +1,497 | New |
| Tower Research Capital LLC (TRC) | 1,461 | $10.0K | 0.00% | +458+45.7% | Added |
| Amalgamated Bank | 720 | $5.00K | 0.00% | +720 | New |
| Simplex Trading, LLC | 322 | $2.00K | 0.00% | +322 | New |
| Parallel Advisors, LLC | 50 | $343 | 0.00% | 00.0% | Unchanged |
| GHP Investment Advisors, Inc. | 20 | $138 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 19 | $130 | 0.00% | −9,231−99.8% | Reduced |
| Allworth Financial LP | 2 | $17 | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 2 | $14 | 0.00% | 00.0% | Unchanged |
| Frazier Financial Advisors, LLC | 1 | $7 | 0.00% | +1 | New |
| Lazard Asset Management LLC | 46 | $0 | 0.00% | −654−93.4% | Reduced |
| Commodore Capital LP | 0 | $0 | 0.00% | −657,333−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −438,935−100.0% | Sold out |
| Samsara BioCapital, LLC | 0 | $0 | 0.00% | −291,666−100.0% | Sold out |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −162,547−100.0% | Sold out |
| Newtyn Management, LLC | 0 | $0 | 0.00% | −46,189−100.0% | Sold out |
| Marathon Trading Investment Management LLC | 0 | $0 | 0.00% | −28,340−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −23,395−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −16,369−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −14,198−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −9,276−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −8,483−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −2,902−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −2,586−100.0% | Sold out |